vs
Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
COASTAL FINANCIAL CORP is the larger business by last-quarter revenue ($138.0M vs $85.1M, roughly 1.6× 4D Molecular Therapeutics, Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -3.6%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CCB vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $85.1M |
| Net Profit | — | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 12.4% | 17.3% |
| Net Margin | — | 22.8% |
| Revenue YoY | -5.8% | 8508900.0% |
| Net Profit YoY | — | 139.1% |
| EPS (diluted) | $0.84 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $85.1M | ||
| Q3 25 | $144.7M | $90.0K | ||
| Q2 25 | $119.4M | $15.0K | ||
| Q1 25 | $139.5M | $14.0K | ||
| Q4 24 | $146.5M | $1.0K | ||
| Q3 24 | $151.1M | $3.0K | ||
| Q2 24 | $135.3M | $5.0K | ||
| Q1 24 | $148.4M | $28.0K |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $13.6M | $-56.9M | ||
| Q2 25 | $11.0M | $-54.7M | ||
| Q1 25 | $9.7M | $-48.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.5M | $-43.8M | ||
| Q2 24 | $11.6M | $-35.0M | ||
| Q1 24 | $6.8M | $-32.4M |
| Q4 25 | 12.4% | 17.3% | ||
| Q3 25 | 12.4% | -67983.3% | ||
| Q2 25 | 12.0% | -396373.3% | ||
| Q1 25 | 8.4% | -383007.1% | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 10.8% | -1704400.0% | ||
| Q2 24 | 11.1% | -849120.0% | ||
| Q1 24 | 5.9% | -136200.0% |
| Q4 25 | — | 22.8% | ||
| Q3 25 | 9.4% | -63195.6% | ||
| Q2 25 | 9.2% | -364386.7% | ||
| Q1 25 | 7.0% | -342657.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.9% | -1461433.3% | ||
| Q2 24 | 8.6% | -699060.0% | ||
| Q1 24 | 4.6% | -115717.9% |
| Q4 25 | $0.84 | $0.43 | ||
| Q3 25 | $0.88 | $-1.01 | ||
| Q2 25 | $0.71 | $-0.98 | ||
| Q1 25 | $0.63 | $-0.86 | ||
| Q4 24 | $0.95 | — | ||
| Q3 24 | $0.97 | $-0.79 | ||
| Q2 24 | $0.84 | $-0.63 | ||
| Q1 24 | $0.50 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $402.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $491.0M | $505.7M |
| Total Assets | $4.7B | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $402.7M | ||
| Q3 25 | — | $305.1M | ||
| Q2 25 | — | $293.2M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | — | $501.9M | ||
| Q2 24 | — | $541.9M | ||
| Q1 24 | — | $525.9M |
| Q4 25 | $491.0M | $505.7M | ||
| Q3 25 | $475.3M | $369.0M | ||
| Q2 25 | $461.7M | $420.9M | ||
| Q1 25 | $449.9M | $469.7M | ||
| Q4 24 | $438.7M | $510.6M | ||
| Q3 24 | $331.9M | $552.9M | ||
| Q2 24 | $316.7M | $588.3M | ||
| Q1 24 | $303.7M | $600.6M |
| Q4 25 | $4.7B | $566.7M | ||
| Q3 25 | $4.6B | $424.0M | ||
| Q2 25 | $4.5B | $473.6M | ||
| Q1 25 | $4.3B | $515.7M | ||
| Q4 24 | $4.1B | $560.4M | ||
| Q3 24 | $4.1B | $604.0M | ||
| Q2 24 | $4.0B | $620.1M | ||
| Q1 24 | $3.9B | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $254.6M | $28.6M |
| Free Cash FlowOCF − Capex | $246.1M | $28.5M |
| FCF MarginFCF / Revenue | 178.3% | 33.5% |
| Capex IntensityCapex / Revenue | 6.1% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $436.4M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $254.6M | $28.6M | ||
| Q3 25 | $59.0M | $-46.5M | ||
| Q2 25 | $66.0M | $-43.4M | ||
| Q1 25 | $71.7M | $-47.8M | ||
| Q4 24 | $259.8M | $-134.6M | ||
| Q3 24 | $62.6M | $-29.4M | ||
| Q2 24 | $72.1M | $-30.2M | ||
| Q1 24 | $56.8M | $-29.1M |
| Q4 25 | $246.1M | $28.5M | ||
| Q3 25 | $57.4M | $-46.6M | ||
| Q2 25 | $64.0M | $-43.4M | ||
| Q1 25 | $68.9M | $-48.4M | ||
| Q4 24 | $249.9M | $-138.4M | ||
| Q3 24 | $60.2M | $-31.2M | ||
| Q2 24 | $69.5M | $-30.6M | ||
| Q1 24 | $55.0M | $-29.8M |
| Q4 25 | 178.3% | 33.5% | ||
| Q3 25 | 39.7% | -51765.6% | ||
| Q2 25 | 53.6% | -289620.0% | ||
| Q1 25 | 49.4% | -345635.7% | ||
| Q4 24 | 170.6% | -13837100.0% | ||
| Q3 24 | 39.8% | -1038966.7% | ||
| Q2 24 | 51.3% | -611840.0% | ||
| Q1 24 | 37.1% | -106421.4% |
| Q4 25 | 6.1% | 0.1% | ||
| Q3 25 | 1.2% | 101.1% | ||
| Q2 25 | 1.7% | 440.0% | ||
| Q1 25 | 2.0% | 4507.1% | ||
| Q4 24 | 6.8% | 378600.0% | ||
| Q3 24 | 1.6% | 59266.7% | ||
| Q2 24 | 1.9% | 6980.0% | ||
| Q1 24 | 1.2% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | 4.34× | — | ||
| Q2 25 | 5.99× | — | ||
| Q1 25 | 7.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.65× | — | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
FDMT
Segment breakdown not available.
